VRAX (VRAX) Stock Price & Analysis
VRAX (VRAX) rose 2.54% to USD 2.63 as of September 8, 2026 at 11:25 UTC, according to Nexqual real-time market data.
VRAX last closed at USD 2.63; the session ranged USD 2.55–2.64 on volume of 21,708 shares. Market capitalization is —, with a 52-week range of USD 2.5–21.75 (NCM). Source: Nexqual, September 8, 2026 at 11:25 UTC.
Key Statistics (as of September 8, 2026 at 11:25 UTC)
| Price | USD 2.63 |
|---|---|
| Change | ▲ 2.54% (up) |
| Previous Close | USD 2.63 |
| Open | USD 2.63 |
| Day Range | USD 2.55 – 2.64 |
| 52-Week Range | USD 2.5 – 21.75 |
| Volume | 21,708 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (VRAX)
Nexqual's technical model rates VRAX "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 11:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36.89 (neutral) |
| vs SMA50 | Below (USD 3.16) |
| MACD | -0.16 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 7.26 | ▲ 7.72% |
| REVB | Revelation Biosciences, Inc. | USD 1.01 | ▲ 1% |
| SOBR | SOBR Safe, Inc. | USD 0.43 | ▼ 5.75% |
| ILAG | Intelligent Living Application | USD 2.9 | ▲ 0% |
| AKAN | Akanda Corp. | USD 3.35 | ▼ 10.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 11:25 UTC. This page is informational and not investment advice.